# Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome.

> **NCT04640324** · NA · COMPLETED · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 92 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- Insulin Resistance

## Interventions

- **DRUG:** Nutraceutical therapy

## Key facts

- **NCT ID:** NCT04640324
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-16
- **Primary completion:** 2017-10-17
- **Final completion:** 2018-04-17
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2020-11-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04640324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04640324, "Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04640324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*